litlas
Log inCreate account

Jonathan Goldin

Active 1996–2025

115
Papers
22,857
Citations
73
h-index
110
i10-index

Citations

Citations per year for Jonathan Goldin1982: 1 citations1990: 1 citations1991: 1 citations1994: 2 citations1997: 2 citations1998: 5 citations1999: 11 citations2000: 15 citations2001: 42 citations2002: 55 citations2003: 84 citations2004: 93 citations2005: 120 citations2006: 101 citations2007: 149 citations2008: 175 citations2009: 167 citations2010: 127 citations2011: 166 citations2012: 166 citations2013: 146 citations2014: 148 citations2015: 152 citations2016: 169 citations2017: 152 citations2018: 188 citations2019: 663 citations2020: 943 citations2021: 844 citations2022: 628 citations2023: 465 citations2024: 710 citations2025: 390 citations2026: 11 citations1983–1989: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,515 citing papers, 26.9% of this breakdownUnited Kingdom: 752 citing papers, 8% of this breakdownGermany: 618 citing papers, 6.6% of this breakdownItaly: 585 citing papers, 6.2% of this breakdownChina: 518 citing papers, 5.5% of this breakdownFrance: 437 citing papers, 4.7% of this breakdownCanada: 411 citing papers, 4.4% of this breakdownNetherlands: 397 citing papers, 4.2% of this breakdownJapan: 322 citing papers, 3.4% of this breakdownSwitzerland: 240 citing papers, 2.6% of this breakdownSpain: 204 citing papers, 2.2% of this breakdownAustralia: 202 citing papers, 2.2% of this breakdown
0%26.9%Other 23.1%

Institutions

Fields

  • Medicine89.6%
  • Biochemistry, Genetics and Molecular Biology3.5%
  • Computer Science2.5%
  • Engineering1.5%
  • Physics and Astronomy0.8%
  • Immunology and Microbiology0.5%
  • Other1.6%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis8.6%
  • Systemic Sclerosis and Related Diseases6.1%
  • Lung Cancer Diagnosis and Treatment5.1%
  • Radiomics and Machine Learning in Medical Imaging4.9%
  • COVID-19 diagnosis using AI3.5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.2%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci‐Cerinic, Oliver Distler, Yoshihito Shima, Jacob M. van Laar, Helen Spotswood, Bridget K. Wagner, Jeffrey Siegel, Angelika Jahreis, Christopher P. Denton, Eleonora Lucero, Bernardo A. Pons‐Estel, Mariano Rivero, Guillermo Tate, Vanessa Smith, Ellen De Langhe, Rasho Rashkov, Anastas Batalov, I Goranov, Румен Стоилов, James V. Dunne, Sindhu R. Johnson, Janet Pope, Dušanka Martinović Kaliterna, Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 cited by 652

  2. The National Lung Screening Trial: Overview and Study Design

    Authors: Constantine A. Gatsonis, Denise R. Aberle, Christine B. Berg, William C. Black, Timothy R. Church, Richard M. Fagerstrom, Barbara Galen, Ilana F. Gareen, Constantine Gatsonis, Jonathan Goldin, John K. Gohagan, Bruce J. Hillman, C. Carl Jaffe, Barnett S. Kramer, David A. Lynch, Pamela M. Marcus, Mitchell D. Schnall, Daniel C. Sullivan, Dorothy Sullivan - Radiology 2010 cited by 1,275

  3. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Authors: Donald P. Tashkin, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Dinesh Khanna, Eric C. Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R. Volkmann, Suzanne Kafaja, Richard M. Silver, Virginia Steen, Charlie Strange, Robert A. Wise, Fredrick M. Wigley, Maureen D. Mayes, D. Jason Riley, Sabiha Hussain, Shervin Assassi, Vivien Hsu, Bela Patel, Kristine Phillips, Fernando J. Martínez, Jeffrey A. Golden, M. Kari Connolly, John Varga, Jane Dematte, Monique Hinchcliff, Aryeh Fischer, Jeffrey J. Swigris, Richard T. Meehan, Arthur C. Theodore, Robert W. Simms, Suncica Volkov, Dean E. Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A. Molitor, Kristin B. Highland, Charles A. Read, Marvin J. Fritzler, Grace Hyun J. Kim, Chi‐Hong Tseng, Robert M. Elashoff - The Lancet Respiratory Medicine 2016 cited by 1,062

  4. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

    Authors: David A. Lynch, Nicola Sverzellati, William D. Travis, Kevin M. Brown, Thomas V. Colby, Jeffrey R. Galvin, Jonathan Goldin, David M. Hansell, Yoshikazu Inoue, Takeshi Johkoh, Andrew G. Nicholson, Shandra L. Knight, Suhail Raoof, Luca Richeldi, Christopher J. Ryerson, Jay H. Ryu, Athol U. Wells - The Lancet Respiratory Medicine 2017 cited by 1,022

  5. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

    Authors: Luca Richeldi, Evans R. Fernández Pérez, Ulrich Costabel, Carlo Albera, David J. Lederer, Kevin R. Flaherty, Neil Ettinger, Rafael L. Perez, Mary Beth Scholand, Jonathan Goldin, Kin-Hung P. Yu, Thomas B. Neff, Seth Porter, Ming Zhong, Eduard Gorina, Elias Kouchakji, Ganesh Raghu - The Lancet Respiratory Medicine 2019 cited by 286

  6. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

    Authors: Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Jonathan Goldin, Michael D. Roth, Daniel E. Furst, Edgar Arriola, Richard M. Silver, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fredrick M. Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky - New England Journal of Medicine 2006 cited by 1,667

  7. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

    Authors: Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst - New England Journal of Medicine 2018 cited by 589

  8. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic

    Authors: Geoffrey D. Rubin, Christopher J. Ryerson, Linda B. Haramati, Nicola Sverzellati, Jeffrey P. Kanne, Suhail Raoof, Neil W. Schluger, Annalisa Volpi, Jae‐Joon Yim, Ian B.K. Martin, Deverick J. Anderson, Christina S. Kong, Talissa A. Altes, Andrew Bush, Sujal R. Desai, Jonathan Goldin, Jin Mo Goo, Marc Humbert, Yoshikazu Inoue, Hans‐Ulrich Kauczor, Fengming Luo, Peter J. Mazzone, Mathias Prokop, Martine Rémy‐Jardin, Luca Richeldi, Cornelia Schaefer‐Prokop, Noriyuki Tomiyama, Athol U. Wells, Ann N. Leung - CHEST Journal 2020 cited by 1,304

  9. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs

    Authors: Jered Sieren, John D. Newell, R. Graham Barr, Eugene R. Bleecker, Nathan Burnette, Elizabeth E. Carretta, David Couper, Jonathan Goldin, Junfeng Guo, MeiLan K. Han, Nadia N. Hansel, Richard E. Kanner, Ella A. Kazerooni, Fernando J. Martínez, Stephen I. Rennard, Prescott G. Woodruff, Eric A. Hoffman - American Journal of Respiratory and Critical Care Medicine 2016 cited by 255

  10. Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

    Authors: Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim Wuyts, Gísli Jenkins, Mary Beth Scholand, Michael Kreuter, Claudia Valenzuela, Christopher J. Ryerson, Jonathan Goldin, Grace Hyun J. Kim, Marzena Jurek, Martin Decaris, Annie Clark, Scott Turner, Chris N. Barnes, Hardean E. Achneck, Gregory P. Cosgrove, Éric Lefebvre, Kevin R. Flaherty - American Journal of Respiratory and Critical Care Medicine 2024 cited by 65

  11. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis

    Authors: Xiaoping Wu, Grace H. Kim, Margaret L. Salisbury, David Barber, Brian J. Bartholmai, Kevin M. Brown, Craig Conoscenti, Jan De Backer, Kevin R. Flaherty, James F. Gruden, Eric A. Hoffman, Stephen M. Humphries, Joseph Jacob, Toby M. Maher, Ganesh Raghu, Luca Richeldi, Brian D. Ross, Rozsa Schlenker‐Herceg, Nicola Sverzellati, Athol U. Wells, Fernando J. Martínez, David A. Lynch, Jonathan Goldin, Simon Walsh - American Journal of Respiratory and Critical Care Medicine 2018 cited by 148

  12. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)

    Authors: Tamera J. Corte, Lisa Lancaster, Jeffrey J. Swigris, Toby M. Maher, Jonathan Goldin, Scott M. Palmer, Takafumi Suda, Takashi Ogura, Anne Minnich, Xiaojiang Zhan, Giridhar Tirucherai, Brandon Elpers, Hong Xiao, Hideaki Watanabe, R. Adam Smith, Edgar D. Charles, Aryeh Fischer - BMJ Open Respiratory Research 2021 cited by 53

  13. Translating AI to Clinical Practice: Overcoming Data Shift with Explainability

    Authors: Youngwon Choi, Wenxi Yu, Mahesh Nagarajan, Pang-yu Teng, Jonathan Goldin, Steven S. Raman, Dieter R. Enzmann, Grace Hyun J. Kim, Matthew S. Brown - Radiographics 2023 cited by 56

  14. Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease

    Authors: David Roofeh, Celia J. F. Lin, Jonathan Goldin, Grace Hyun J. Kim, Daniel E. Furst, Christopher P. Denton, Suiyuan Huang, Dinesh Khanna, the focuSSced Investigators - Arthritis & Rheumatology 2021 cited by 191

  15. Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial

    Authors: Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Bridget K. Wagner, Mauro Zucchetto, Ganesh Raghu, Fernando J. Martínez, Jonathan Goldin, Jeffrey Siegel, Christopher P. Denton - American Journal of Respiratory and Critical Care Medicine 2021 cited by 132

  16. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

    Authors: Ganesh Raghu, Marya Ghazipura, Thomas R. Fleming, Kerri I. Aronson, Jürgen Behr, Kevin M. Brown, Kevin R. Flaherty, Ella A. Kazerooni, Toby M. Maher, Luca Richeldi, Joseph A. Lasky, Jeffrey J. Swigris, Robert Busch, Lili Garrard, Dong-Hyun Ahn, Ji Li, Khalid Puthawala, Gabriela Rodal, Sally Seymour, Nargues Weir, Sonye K. Danoff, Neil Ettinger, Jonathan Goldin, Marilyn K. Glassberg, Letícia Kawano-Dourado, Nasreen Khalil, Lisa Lancaster, David A. Lynch, Yolanda Mageto, Imre Noth, Jessica Shore, Marlies Wijsenbeek, Robert S. Brown, Daniel Grogan, Dorothy Ivey, Patrycja Golińska, Banu A. Karimi-Shah, Fernando J. Martínez - American Journal of Respiratory and Critical Care Medicine 2024 cited by 76

  17. Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

    Authors: William G. Goodman, Jonathan Goldin, Beatriz D. Kuizon, Chun Yoon, Barbara Gales, Donna Sider, Yan Wang, Joanie Chung, Aletha M. Emerick, Lloyd E. Greaser, Robert M. Elashoff, Isidro B. Salusky - New England Journal of Medicine 2000 cited by 2,504

  18. CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a Position Paper from the Fleischner society

    Authors: David M. Hansell, Jonathan Goldin, Talmadge E. King, David A. Lynch, Luca Richeldi, Athol U. Wells - The Lancet Respiratory Medicine 2015 cited by 185

  19. Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months

    Authors: Hyun J. Kim, Hyun J. Kim, Matthew S. Brown, Daniel Chong, David W. Gjertson, Peiyun Lu, Hak J. Kim, Hak J. Kim, Heidi Coy, Jonathan Goldin - Academic Radiology 2014 cited by 127

  20. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib

    Authors: Benjamin M. Ellingson, Grace Hyun J. Kim, Matt Brown, Jihey Lee, Noriko Salamon, Lori Steelman, Islam Hassan, Shuchi S. Pandya, Saewon Chun, Michael Linetsky, Bryan Yoo, Patrick Y. Wen, Ingo K. Mellinghoff, Jonathan Goldin, Timothy F. Cloughesy - Neuro-Oncology 2021 cited by 63

  21. Assessment of Coronary Artery Disease by Cardiac Computed Tomography

    Authors: Matthew J. Budoff, Stephan Achenbach, Roger S. Blumenthal, J. Jeffrey Carr, Jonathan Goldin, Philip Greenland, Alan D. Guerci, João A.C. Lima, Daniel J. Rader, Geoffrey D. Rubin, Leslee J. Shaw, Susan E. Wiegers - Circulation 2006 cited by 1,399

  22. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

    Authors: Elizabeth R. Volkmann, Donald P. Tashkin, Ning Li, Michael D. Roth, Dinesh Khanna, Anna‐Maria Hoffmann‐Vold, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Robert M. Elashoff - Arthritis & Rheumatology 2017 cited by 159

  23. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study

    Authors: Sujal R. Desai, Nishanth Sivarasan, Kerri A. Johannson, Peter M. George, Daniel A. Culver, Anand Devaraj, David A. Lynch, David Milne, Elisabetta Renzoni, Hilario Nunès, Nicola Sverzellati, Paolo Spagnolo, Robert P. Baughman, Ruchi Yadav, Sara Piciucchi, Simon Walsh, Vasileios Kouranos, Athol U. Wells, Adam Anderson, Adam S. Morgenthau, Adrián Gaser, А. A. Vizel, Alexandra Speranskaya, Alicia K. Gerke, Altinisik Goksel, Álvaro Undurraga, Amita Sharma, Andrea Oh, Ann N. Leung, Anna Rita Larici, Antje Prasse, Antonietta Mazzei, António Morais, Ashu Seith Bhalla, Belén del Río, Bhavin Jankharia, Brett M. Elicker, Carlos A.C. Pereira, Catherine Biegelman-Aubry, Charles S. White, Claudia Ravaglia, Connie C. W. Hsia, Cornelia Schaefer‐Prokop, David Launay, Deepak Talwar, Diego Castillo, Divya Patel, Dominique Israël‐Biet, Dominique Valeyre, E. James Britt, Elena Bargagli, Elisabeth Bendstrup, Elliott D. Crouser, Esther J. Nossent, Eugeny Shmelev, Eva Carmona Porquera, Francesco Bonella, Fleur Cohen‐Aubart, Florence Jeny, Giovanni Ferrara, Gong Yong Jin, Hasti Robbie, Helmut Prosch, Hiromitsu Sumikawa, Ho Ling-Pei, Ho Yun Lee, Irina Strâmbu, Ivette Buendía-Roldán, Jan Grutters, Jay H. Ryu, Jeff Swigris, Jelle Miedema, Jin Mo Goo, Joseph Barnett, Johny Verschakelen, Jonathan Goldin, Joon Beom Seo, Juan Ignacio Enghelmayer, Juan Mañá, Juergen Behr, Karen Patterson, Κατερίνα Αντωνίου, Kevin M. Brown, Kiminori Fujimoto, Laurent Savale, Lisa A. Maier, Luca Richeldi, Manuel L. Ribeiro Neto, Marc Humbert, Marc A. Judson, Marcel Veltkamp, Margaret Wilsher, María Molina‐Molina, María Otaola, Marie‐Pierre Revel, Mario Silva, Marjolein Drent, Mark L. Schiebler, Marlies Wijsenbeek-Lourens, Martina Bonifazi and 50 more - The Lancet Respiratory Medicine 2023 cited by 67

  24. A Randomized Study of Endobronchial Valves for Advanced Emphysema

    Authors: Frank C. Sciurba, Armin Ernst, Felix Herth, Charlie Strange, Gerard J. Criner, Charles‐Hugo Marquette, Kevin L. Kovitz, Richard P. Chiacchierini, Jonathan Goldin, Geoffrey McLennan - New England Journal of Medicine 2010 cited by 848